Stakeholders may be mining US FDA Commissioner nominee Stephen Hahn's answers to questions about e-cigarettes and other non-pharma issues for clues about his drug policy stances.
Hahn almost surely will be asked some questions about drug development and approval during his 20 November confirmation hearing